ResearcherMasaryk UniversityNo recent work listed
Ondřej Slabý
Matched on ORCID iD 0000-0002-8450-0584; OpenAlex author ID A5090844895. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 15
2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: 2 papers
Papers 7
- The Role of Circulating MicroRNAs in Patients with Early-Stage Pancreatic Adenocarcinoma. Co-author DOI 10.3390/biomedicines9101468↗
- Current view of neoadjuvant chemotherapy in primarily resectable pancreatic adenocarcinoma. Co-author DOI 10.4149/neo_2020_200408n372↗
- Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection. Last author DOI 10.3390/jcm9082440↗
- Cell-free microRNAs as Non-invasive Diagnostic and Prognostic Bio- markers in Pancreatic Cancer. Co-author DOI 10.2174/1389202921666191217095017↗
- Analysis of Blood Plasma MicroRNAs to Enable Identification of Patients with Pancreatic Ductal Adenocarcinoma Who Will Benefit from Surgical Resection Last author PMID 31064193↗
- Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical… Co-author DOI 10.21873/cgp.20090↗
- MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma. Last author DOI 10.1186/s13000-015-0272-6↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zdeněk Kala · 7 shared papers, 2015–2021 · strength 0.71
- Paper The Role of Circulating MicroRNAs in Patients with Early-Stage Pancreatic Adenocarcinoma. DOI 10.3390/biomedicines9101468↗
- Paper Cell-free microRNAs as Non-invasive Diagnostic and Prognostic Bio- markers in Pancreatic Cancer. DOI 10.2174/1389202921666191217095017↗
- Paper Current view of neoadjuvant chemotherapy in primarily resectable pancreatic adenocarcinoma. DOI 10.4149/neo_2020_200408n372↗
- Igor Kišš · 5 shared papers, 2015–2020 · strength 0.45
- Paper Cell-free microRNAs as Non-invasive Diagnostic and Prognostic Bio- markers in Pancreatic Cancer. DOI 10.2174/1389202921666191217095017↗
- Paper Analysis of Blood Plasma MicroRNAs to Enable Identification of Patients with Pancreatic Ductal Adenocarcinoma Who Will … PMID 31064193↗
- Paper Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Pat… DOI 10.3390/jcm9082440↗
- Jan Hlavsa · 5 shared papers, 2015–2021 · strength 0.45
- Paper Current view of neoadjuvant chemotherapy in primarily resectable pancreatic adenocarcinoma. DOI 10.4149/neo_2020_200408n372↗
- Paper Analysis of Blood Plasma MicroRNAs to Enable Identification of Patients with Pancreatic Ductal Adenocarcinoma Who Will … PMID 31064193↗
- Paper Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Pat… DOI 10.3390/jcm9082440↗
- Natalia Gabło · 4 shared papers, 2018–2020 · strength 0.41
- Paper Cell-free microRNAs as Non-invasive Diagnostic and Prognostic Bio- markers in Pancreatic Cancer. DOI 10.2174/1389202921666191217095017↗
- Paper Analysis of Blood Plasma MicroRNAs to Enable Identification of Patients with Pancreatic Ductal Adenocarcinoma Who Will … PMID 31064193↗
- Paper Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Pat… DOI 10.3390/jcm9082440↗
- Vladimír Procházka · 4 shared papers, 2015–2020 · strength 0.35
- Paper Cell-free microRNAs as Non-invasive Diagnostic and Prognostic Bio- markers in Pancreatic Cancer. DOI 10.2174/1389202921666191217095017↗
- Paper Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Pat… DOI 10.3390/jcm9082440↗
- Paper Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic D… DOI 10.21873/cgp.20090↗
- Michal Eid · 2 shared papers, 2021 · strength 0.25
- Jiřı́ Mayer · 2 shared papers, 2021 · strength 0.25
- Lumír Kunovský · 2 shared papers, 2021 · strength 0.25
- Jan Trna · 1 shared paper, 2021 · strength 0.13
- Markéta Hermanová · 2 shared papers, 2015–2018 · strength 0.12
- Paper Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic D… DOI 10.21873/cgp.20090↗
- Paper MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic du… DOI 10.1186/s13000-015-0272-6↗
- Petra Vychytilova‐Faltejskova · 2 shared papers, 2015–2018 · strength 0.12
- Paper Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic D… DOI 10.21873/cgp.20090↗
- Paper MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic du… DOI 10.1186/s13000-015-0272-6↗
- Petr Karásek · 2 shared papers, 2015–2018 · strength 0.12
- Paper Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic D… DOI 10.21873/cgp.20090↗
- Paper MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic du… DOI 10.1186/s13000-015-0272-6↗
- Martin Loveček · 1 shared paper, 2020 · strength 0.10
- Ioana Berindan‐Neagoe · 1 shared paper, 2020 · strength 0.10
- Jiří Lenz · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.